CS
TEVA icon

Candriam SCA’s Teva Pharmaceuticals TEVA Stock Holding History

Candriam SCA’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$18.6M Buy
550,523
+82,961
+18% +$2.76M 0.08% 211
2026
Q1 		$14.1M Buy
+467,562
New +$15M 0.07% 233
2020
Q3 		– Hold
0
– – – 477
2018
Q2 		– Sell
-70,631
Closed -$1.21M – 824
2018
Q1 		$1.21M Sell
70,631
-1,277
-2% -$24.9K 0.02% 557
2017
Q4 		$1.36M Buy
71,908
+20,000
+39% +$301K 0.02% 526
2017
Q3 		$914K Buy
51,908
+40,033
+337% +$901K 0.02% 583
2017
Q2 		$395K Sell
11,875
-1,201
-9% -$37.2K 0.01% 668
2017
Q1 		$420K Sell
13,076
-42,064
-76% -$1.44M 0.01% 656
2016
Q4 		$2M Buy
55,140
+4,007
+8% +$160K 0.05% 372
2016
Q3 		$2.35M Sell
51,133
-8,066
-14% -$421K 0.06% 328
2016
Q2 		$2.97M Sell
59,199
-1,354
-2% -$72.1K 0.08% 251
2016
Q1 		$3.22M Buy
60,553
+7,560
+14% +$444K 0.08% 256
2015
Q4 		$3.48M Sell
52,993
-6,000
-10% -$371K 0.09% 232
2015
Q3 		$3.33M Sell
58,993
-43,730
-43% -$2.84M 0.08% 258
2015
Q2 		$6.07M Sell
102,723
-1,318
-1% -$81.3K 0.13% 206
2015
Q1 		$6.48M Buy
104,041
+28,340
+37% +$1.65M 0.13% 205
2014
Q4 		$4.35M Buy
+75,701
New +$4.22M 0.09% 258

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Candriam SCA's TEVA Position: Q2 2026 in Review

Candriam SCA increased its Teva Pharmaceuticals (TEVA) stake by 18% in Q2 2026, buying an estimated $2.76M and bringing the position to 550,523 shares worth $18.6M. The position accounts for 0.08% of the portfolio, ranked #211.

Candriam SCA first reported a position in TEVA in Q4 2014 and has held it in 16 quarters since. 673 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Candriam SCA held 550,523 shares of Teva Pharmaceuticals worth $18.6M as of Q2 2026.
  • Candriam SCA bought 82,961 Teva Pharmaceuticals shares in Q2 2026, an estimated $2.76M.
  • Teva Pharmaceuticals made up 0.08% of Candriam SCA's portfolio in Q2 2026, its #211 holding.
  • Candriam SCA first reported a position in Teva Pharmaceuticals in Q4 2014 and has held it in 16 quarters since.
  • 673 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Candriam SCA's 13F filing for Q2 2026, filed 13 Aug 2026.